Morning Briefing
April 10, 2024 | Daily JAM, Morning Briefing, Short Term |
In March the Consumer Price Index inflation rate rose more than expected by economists for a third straight month, the Bureau of Labor Statistics reported this morning. That looks to the market today, and to me, like it takes an initial interest rate cut off the table for the Fed’s June 12 meeting. The all-items inflation rate rose by 0.4% in March from February. The 12-month all-items inflation rate rose at a 3.5% rate in March. The core CPI, the inflation rate more important to the Federal Reserve, rose 0.4% month-over-month in March. And at a 3.8% annual rate.
April 9, 2024 | AMD, Daily JAM, GOOG, Morning Briefing, NVDA |
Nvidia (NVDA) doesn’t report earnings until May 22. But the report is already shaping up as critical for the stock. Analysts see the company reporting earnings of $5.13 a share for the quarter, up from just 88 cents a share in the same quarter of 2023.
But the short-term earnings numbers aren’t what’s most importance right now. Nvidia has roughly 90% share in the market for AI-accelator chips. That’s put a big target on the company’s back. No one expects Nvidia is maintain that 90% share–which is okay since the market is growing so fast. Last month, analysts at Bank of America said the market could reach anywhere between $250 billion and $500 billion over the next three to five years. That was a big jump from their earlier estimate of less than $250 billion. The question is How fast all the efforts to compete with Nvidia will eat into that market share.
April 8, 2024 | Daily JAM, Morning Briefing |
Yields on the 10-year Treasury rose to the highest since November, climbing to 4.42%. That an increase in the 10-year yield of 25 basis points in the last month. The bond market looks to have given up its hope for three interest rate cuts in 2024 now to be looking now to just two moves by the Federal Reserve in 2024. Wednesday’s release of CPI inflation numbers for March will confirm or reverse that conviction
April 7, 2024 | Daily JAM, Morning Briefing, Short Term |
This week I expect the market to put its obsession with the Federal Reserve, inflation, and interest rates on hold, and switch to watching earnings reports for the first quarter of 2024. The first batch of earnings–the Big Banks JPMorgan Chase (JPM), Citigroup (C), and Wells Fargo (WFC)–hits the wires on Friday, April 12–with Netflix (NFLX) to begin tech/momentum earnings reports on Tuesday, April 18. I think it would be an overstatement to say that the quarter’s earnings reports are make or break for this rally–the economic news is just too strong and interest rate cuts loom out there somewhere even if no one can say just when. But this quarter will provide an important data point in the “Stocks have climbed too far, too fast” vs. “This rally can run higher on a strong economy” debate. And the first set of high-profile earnings looks likely to throw some cold water on the most fevered market optimists.
April 5, 2024 | Daily JAM, Morning Briefing |
The U.S. economy added 303,000 jobs last month. That was far more than than the 192,000 expected by economists.The unemployment rate dipped to 3.8%.
For today at least the stock market sees the report as “The glass is half full.” Yes, a stronger than expected labor market raises the odds that the Federal Reserve won’t begin its interest rate cuts at its June 12 meeting. But the strength in the economy is good for stocks. And if not June, then the Fed will cut in July, the thinking goes today.
April 3, 2024 | Daily JAM, Morning Briefing |
The Institute for Supply Management’s composite index of services fell 1.2 points to 51.4 a four-year low. The drop in the report released today, April 3, was the second month in a row. The services report came a day after the manufacturing sector report showed costs rising in the sector. Which, of course, led some investors and traders to worry that the Federal Reserve might put off the start of interest rate cuts beyond its June 12 meeting. The yield on the 10-year Treasury, which hit a new intraday high for 2024 at 4.37% yesterday, closed at 4.35% today. That’s still 17 basis points higher in a month. The relative calm today was also a result of remarks from Jerome Powell and other Fed officials that boiled down to “We told you the road to 2% inflation would be bumpy, but we haven’t seen anything in the recent data to change the direction of our policy or the timing of cuts.” A June cut, in other words, remains very much on the table.
April 2, 2024 | BYDDF, Daily JAM, Jubak Picks, Morning Briefing |
Today, Tesla (TSLA) reported that it delivered just 386,810 vehicles in the first three months of the year. That was the biggest difference between actual sales and Wall Street sales estimates in data going back seven years, according to Bloomberg. Most analysts expected Tesla to sell more vehicles than a year ago. Instead, deliveries ended up dropping 8.5% year-over-year. And it was the first drop in year-over-year sales since the first year of the Covid-19 pandemic.
April 1, 2024 | Daily JAM, Morning Briefing |
Could it be just two interest rate cuts in 2024 instead of three (or four as the most bullish wish)? The Institute for Supply Management’s manufacturing index showed U.S. factory activity unexpectedly expanding in March for the first time since September 2022 on a sharp rebound in production and stronger demand. Even worse, for those counting on early and often cuts from the Fed, input costs, AKA inflation, climbed.
March 31, 2024 | Daily JAM, Morning Briefing, Short Term |
Maybe no one ever expects the Spanish Inquisition, but we all know by now to expect the monthly jobs report to be a big deal for this market. On Friday, April 5, the Bureau of Labor Statistics will report on nonfarm payrolls for March. Economists expect 216,000 nonfarm jobs to have been added in March.
March 28, 2024 | AAPL, Daily JAM, Jubak Picks, Morning Briefing, Short Term, Top 50 Stocks |
Apple is likely to take its shareholders on an even wilder ride in the next six months than they’ve been on since the December all-time high at $199.62. The end result, I think is likely to be a renewed rally beginning in the fall–if you can either hold on through the volatility until then or see your way clear to timing when to buy and sell.
March 26, 2024 | Daily JAM, Jubak Picks, LLY, Mid Term, Morning Briefing, NVO, Stock Alerts, VKTX |
First, it was Viking Therapeutics (VKTX) on the attack with trial results that shows its GLP-1 dibetes/weight loss drug out performing current leader of the pack drugs fro Novo Nordisk (NVO) and Eli Lilly (LLY). On the news Viking soared.
Then Novo Nordisk struct back with data of its own showing progress on an oral formulation of its rugs. (All existing GLP-1 drugs are delivered by injection.) That cratered Viking Shares. Now, March 26, Viking has released new Phase 1 trial data from a multiple ascending dose study of the oral version of VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
March 22, 2024 | Daily JAM, Long Term, Morning Briefing |
You know the saying, When all you have is a hammer, every problem looks like a nail? How about this data world version, When you don’t track the data, you can’t see the problem? I was drawn to paraphrase the classic hammer/nail adage by the release of the Federal Reserve’s most recent economic projections, the Dot Plot, on Wednesday, March 20 when I thought about the economic data the Fed didn’t include in its projections.
